FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Register
horizonal rule

 

Advisory Committees

Waivers for Conflicts of Interest

The Food and Drug Administration Amendments Act of 2007 (FDAAA), enacted on September 27, 2007, added a new provision regarding financial conflicts of interest, § 712 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), effective October 1, 2007. Accordingly, for advisory committee meetings after October 1, 2007, FDA is granting waivers under 18 U.S.C. § 208 and § 712 of the FD&C Act, where applicable, when the relevant waiver standards in these statutes are met.

Waivers under 21 U.S.C. § 355(n)(4) were issued before October 1, 2007.  This provision was repealed, effective October 1, 2007, by the FDA.

Nature and Basis Statement of Conflict(s) of Interest for Voting Members of FDA Advisory Committee

 
Cellular, Tissue and Gene Therapies Advisory Committee

May 15, 2009

Richard D. Coutts, M.D.

  • 18 U.S.C. 208(b)(3) /712(c)(2)(B) waiver (pdf)
  • Acknowledgement and Consent (pdf)

Page updated: April 30, 2009

horizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Federal Registers
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management
[Skip Navigation] link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page